SCHEMBL1972879

SCHEMBL1972879

O=C(OCc1ccccc1)[N+]1([O-])CC=CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
LMNA P02545 3/20 0.44
HCAR2 Q8TDS4 1/20 0.44
FABP7 O15540 1/20 0.42
FABP5 Q01469 1/20 0.42
MEN1 O00255 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TSHR P16473 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167580 0.83 ALDH1A1 (0.49) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL9785319 0.83 ALDH1A1 (0.49) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL1128419 0.82 ALDH1A1 (0.47) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL14830807 0.72 ALDH1A1 (0.44) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL103623 0.70 ALDH1A1 (0.63) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL30001820 0.69 ALDH1A1 (0.68) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL37382 0.69 ALDH1A1 (0.68) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL78553 0.69 ALDH1A1 (0.68) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL27144 0.69 ALDH1A1 (0.68) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL5849243 0.69 ALDH1A1 (0.47) ALDH1A1TDP1KMT2AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404866-B2 Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-03-26 US disclosed
US-20110144179-A1 Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144179-A1 Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors MMP7, MMP1, MMP9 ALDH1A1 491/4885TDP1 1222/4885KMT2A 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.